BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
16.15
-0.10 (-0.62%)
At close: Mar 27, 2026, 4:00 PM EDT
16.00
-0.15 (-0.93%)
After-hours: Mar 27, 2026, 5:58 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $716.73 million as of March 27, 2026. Its market cap has increased by 376.03% in one year.
Market Cap
716.73M
Enterprise Value
437.16M
1-Year Change
376.03%
Ranking
Category
Stock Price
$16.15
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $716.73M, an increase of 16.54%. That is a compound annual growth rate of 10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 716.73M | 51.09% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 1.03B |
| Pacira BioSciences | 984.33M |
| Alvotech | 973.49M |
| Cronos Group | 960.82M |
| Amphastar Pharmaceuticals | 862.49M |
| Evotec SE | 859.36M |
| Tilray Brands | 736.32M |
| Esperion Therapeutics | 703.66M |